Theratechnologies Inc. (TH.TO)

Trade TH.TO now with
7/23/2020 4:33:29 PM Theratechnologies: Sub-analysis Of MGH Study Helps Better Show How Tesamorelin Reduces Liver Fat
10/10/2019 7:41:12 AM Theratechnologies Plans NASDAQ Listing
9/19/2019 7:38:49 AM Theratechnologies Enters Agreement With ADAP For New EGRIFTA SV
8/12/2019 7:40:47 AM Theratechnologies Applies To List Its Common Shares On NASDAQ
6/17/2019 9:18:27 AM Theratechnologies To Pursue Development Of Tesamorelin For NASH In HIV
3/29/2019 10:05:01 AM Theratechnologies Names Sheila Frame To Its Board
11/5/2018 7:37:01 AM Theratechnologies: FDA Approves Novel Single-Vial Formulation Of EGRIFTA
10/30/2018 7:43:49 AM Trogarzo Phase III Data Analysis Presented At HIV Drug Therapy Glasgow 2018
8/20/2018 7:51:15 AM European Medicines Agency Authorizes Deferral Of Paediatric Investigation Plan For Trogarzo
7/4/2018 7:30:42 AM Theratechnologies Submits Novel Single-Vial Formulation Of EGRIFTA For FDA Approval
5/1/2018 7:33:43 AM FDA Releases Theratechnologies From Post-Approval Commitments Related To EGRIFTA(Tesamorelin For Injection)
4/30/2018 7:32:28 AM Theratechnologies Says Trogarzo(TM) (Ibalizumab-Uiyk) Injection Is Now Available In The U.S.
4/5/2018 7:33:01 AM Theratechnologies Q1 Net Sales $10.2 Mln, Up 13%